They were described as markers of placental abnormality (e.g., INHBA, ADAM12, PGF), preeclampsia risk (e.g., PAPPA2, KISS1, CLIC3), and placental hypoxia (e.g., ANGPTL4). This evidence concerns the gene ADAM12 and preeclampsia.